Analyst Initiates Coverage with 'BUY' Rating
ICICI Securities has started covering Hyundai Motor India Limited (HMIL) with a 'BUY' rating and a price target of INR 2,150, using a 25x FY28 earnings per share multiple. The positive outlook is based on HMIL's ambitious product pipeline, which includes 26 new models, seven of them entirely new names, planned between fiscal years 2026 and 2030. The goal is to fill gaps in its offerings and regain market share in the competitive domestic utility vehicle (UV) segment, where it has lost ground due to strong rivalry and heavy reliance on the popular Creta model.
Recent Performance and Market Trends
However, HMIL's domestic sales have faced challenges, dropping 5% year-on-year in April 2025. In the first quarter of fiscal year 2026 (April-June 2025), HMIL's UV sales volume was 90,531 units, a 10% decrease from the previous year. This led to a decline in its UV market share to 13.50%, down from 15.60% a year ago, highlighting the difficulty in regaining momentum against rivals.
Indian Auto Sector Faces Slowdown, Competition Heats Up
The Indian auto sector is heading into a period of slower growth, with overall volume expected to rise 3-6% for FY2026-27 after a strong prior year. Passenger vehicles are forecast to grow 4-6%, supported by trends such as premium models, electric vehicles, and recovery in rural demand. However, the UV segment itself saw only mild 3.8% year-on-year growth in Q1 FY2026. Most vehicle manufacturers reported sales drops, with a few exceptions like Mahindra & Mahindra.
Key Competitors and Valuation
Maruti Suzuki, the market leader, held a 24% UV market share in Q1 FY2026, down slightly from 25%. Mahindra & Mahindra (M&M) captured 23% with strong year-on-year growth. HMIL's lower share shows the fierce competition. Valuations as of March/April 2026 show Maruti Suzuki's P/E at 25.5x-27.3x and M&M at 20.5x-24.4x. Hyundai Motor India's P/E is around 24.95x-27.7x, similar to Maruti Suzuki but higher than M&M. ICICI Securities' target P/E of 25x FY28 EPS is close to these current levels, suggesting the target price might already include anticipated earnings and competitive standing, rather than room for higher valuation multiples.
Export Performance and Growth Avenue
HMIL's market capitalization was about INR 1.44 trillion on March 30, 2026. Exports saw a strong 21% year-on-year increase in April 2025, but the research report notes this is a limited long-term growth path, even though it helps with immediate growth.
Execution Risks and Competitive Threats
Despite positive forecasts for new models, significant execution risks persist. HMIL's sales growth over the past five years was a modest 9.50%, and its heavy dependence on the Creta model remains a weakness. The ambitious product launch plan, though needed, carries risks like internal cannibalization, development delays, and potential lack of market acceptance, particularly against agile competitors like Maruti Suzuki and M&M who are also investing in new UVs.
Margin Pressure and Profitability Concerns
Intense competition in the Indian auto market also risks squeezing profit margins. While HMIL shows a strong three-year return on equity (ROE) of about 34.8% and a dividend payout ratio of 49.7%, its stock trades at 8.50 times its book value. Previous financials reveal inconsistent profitability, with Profit After Tax (PAT) seeing sharp year-on-year drops in some quarters, like a 21.49% fall in the December 2025 quarter. Slower auto sector growth expected in FY2026-27 adds to concerns that HMIL's new product plans might not be enough to overcome a market slowdown and tough competition.
Growth Projections and Target Price
ICICI Securities forecasts HMIL's volume, EBITDA, and PAT to grow at compound annual rates of around 9%, 13%, and 12% respectively, from FY26-28. This projection relies on new product launches and an expected return on invested capital above 35%. The INR 2,150 target price, based on a 25x FY28 EPS multiple, implies about a 15% upside from its April 1, 2026 trading price of INR 1,792. However, the success of this large new product lineup is a key factor to watch. Any stumbles could force a reassessment of growth forecasts and valuation multiples, especially in a market that closely examines execution.